<DOC>
	<DOCNO>NCT00493831</DOCNO>
	<brief_summary>The purpose prospective , open-label , clinical trial establish feasibility validity exhale breath condensate ( EBC ) biomarkers use study design evaluate harm reduction strategy smoke . This accomplish measure select marker EBC believe related pathogenesis lung disease smoke cessation intervention .</brief_summary>
	<brief_title>Analysis Lipid Biomarkers Exposure Host Response</brief_title>
	<detailed_description>Twenty subject accrue three group base smoke habit : 10-20 , 20-30 &gt; 30 cigarettes/day . Eligibility criterion include male female cigarette smoker ≥19 year age , able give inform consent , able exhale Eco Screen instrument 15-20 minute . All must willing make serious quit attempt willing use nicotine replacement therapy . Subjects exclude follow present : regular use anti-inflammatory medication ; presence inflammatory disease respiratory tract include moderate worse COPD ( FEV1 &lt; 80 % predict FEV1/FVC ratio &lt; 0.7 ) . Subjects normal lung function meet criterion diagnosis chronic bronchitis exclude . Subjects stable medical condition , exclude inflammatory lung disease , permit participate , provide anti-inflammatory therapy use regularly provide change clinical status two month prior begin study . Upon enter study , subject establish quit date treat nicotine replacement therapy ( NRT ) product base individual preference receive smoke cessation counseling . They see 12 visit course 25 week . Evaluations include vital sign , interval smoke history , food frequency questionnaire , exhale carbon monoxide , blood drawn chemistry CBC , peripheral blood harvest serum aliquoted saved future biochemical analysis , urine sample isoprostane , pregnancy test female , exhale breath condensate . Some visit may also include spirometry bronchodilator , 24 hour urine collection NNAL NNAL-glc quantification , health status assess use St. George ’ Respiratory Questionnaire , Functional Assessment Chronic Illness Therapy – Fatigue , Leicester Cough Questionnaire , Clinical COPD Questionnaire smoking relate symptom assess use Breathlessness , Cough , Sputum Scale .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Smoke least 5 pack year Have stable smoking habit 3 month Be willing make serious quit attempt Be able use nicotine replacement therapy Regular use antiinflammatory medication Presence inflammatory lung disease Unstable medical condition</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>smoke reduction</keyword>
	<keyword>inflammation</keyword>
	<keyword>harm reduction</keyword>
	<keyword>lipid biomarkers</keyword>
</DOC>